Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис:
http://hdl.handle.net/20.500.12188/34995| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Atanasova Nadzinska, M | en_US |
| dc.contributor.author | Jakjovska Maretti, Tatjana | en_US |
| dc.contributor.author | Momchilovikj, Sonja | en_US |
| dc.contributor.author | Arnaudova Danevska, Ivana | en_US |
| dc.date.accessioned | 2026-02-25T09:39:10Z | - |
| dc.date.available | 2026-02-25T09:39:10Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/34995 | - |
| dc.description.abstract | A major problem in the treatment of cystic fibrosis is nonadherence to inhaled therapies, which can influence lung function and health outcomes in patients with cystic fibrosis (CF). Our aim is to determine the adherence to inhaled therapy after providing medications closer to home and the active role of the pharmacist in the process and education of patients. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier BV | en_US |
| dc.relation.ispartof | Journal of Cystic Fibrosis | en_US |
| dc.title | The role of the clinical pharmacy specialist in monitoring adherence to inhaled therapies in patients with cystic fibrosis in the Republic of North Macedonia | en_US |
| dc.type | Proceeding article | en_US |
| dc.relation.conference | 44th European Cystic Fibrosis Conference, Digital | en_US |
| dc.identifier.doi | https://doi.org/10.1016/S1569-1993(21)01148-6 | - |
| item.fulltext | With Fulltext | - |
| item.grantfulltext | open | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Conference papers | |
Files in This Item:
Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.